PrecISE Severe Asthma Interventions Request More Information Trial Objective The purpose of this study is to understand how to treat different types of severe asthma using precision medicine. Precision medicine is an approach that targets treatments to defined subgroups of patients who share similar characteristics. For example, patients who have a certain genetic variation or patients with high number of blood eosinophils. Study participants will receive several treatments based on their type of severe asthma for research purposes. Enrollment Active Clinical Trials Currently Recruiting Who Can Participate Individuals 12 years of age and older whose asthma symptoms are not well-controlled on high dose of inhaled corticosteroids, including those who have frequent asthma attacks. Age: 12+ Gender: Any Gender Estimated Time Commitment 3 phases, approximately 9 visits per phase for up to 2 years × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Allen Stevens 303.398.1443 Michael White Pediatric Coordinator 303.398.1417 Request More Information Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors National Institutes of Health Principal Investigators Michael Wechsler, MD, MMSc + × Michael Wechsler, MD, MMSc Director, The Cohen Family Asthma Institute Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine View Full Profile Patient Rating 4.9 out of 5 stars Make an Appoinment Co-Investigators Laurie Manka, MD + × Laurie Manka, MD Associate Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine View Full Profile Patient Rating 4.9 out of 5 stars Make an Appoinment Pamela Zeitlin, MD, MPhil, PhD + × Pamela Zeitlin, MD, MPhil, PhD Silverstein Chair, Department of Pediatrics Professor of Pediatrics View Full Profile Patient Rating 4.8 out of 5 stars Make an Appoinment Rafeul Alam, MD, PhD + × Rafeul Alam, MD, PhD Chief, Division of Allergy & Clinical Immunology Professor Veda H. and Chauncey H. Ritter Chair in Immunology Department of Medicine Division of Allergy & Clinical Immunology View Full Profile Patient Rating 4.8 out of 5 stars Make an Appoinment Ronina Covar, MD + × Ronina Covar, MD Associate Co-Director, The Cohen Family Asthma Institute Head, Pediatric Clinical Pharmacology Consult Service Associate Professor Division of Pediatric Allergy & Clinical Immunology Department of Pediatrics View Full Profile Patient Rating 4.8 out of 5 stars Make an Appoinment Vamsi Guntur, MD, MSc + × Vamsi Guntur, MD, MSc Associate Professor Division of Pulmonary, Critical Care & Sleep Medicine Department of Medicine View Full Profile Patient Rating 4.7 out of 5 stars Make an Appoinment Request More Information By completing this form, you agree to learn more about this study and see if you qualify. First Name:* Last Name:* Email Address:* Phone:* I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: YesNo
Trial Objective The purpose of this study is to understand how to treat different types of severe asthma using precision medicine. Precision medicine is an approach that targets treatments to defined subgroups of patients who share similar characteristics. For example, patients who have a certain genetic variation or patients with high number of blood eosinophils. Study participants will receive several treatments based on their type of severe asthma for research purposes.